About the Male Breast Cancer Session
Male breast cancer is a lesser-known but significant aspect of cancer research. Although it's comparatively rare, comprising less than 1% of all breast cancer cases, understanding its unique characteristics is crucial for effective diagnosis and treatment. Unlike in females, male breast cancer is often diagnosed at later stages due to less awareness and a lack of routine screening. Research in this field focuses on elucidating the genetic, hormonal, and environmental factors contributing to its development, as well as refining treatment strategies tailored specifically for male patients. Early detection methods and targeted therapies are areas of active investigation to improve outcomes for men affected by this condition. By advancing our understanding of male breast cancer, researchers aim to mitigate its impact and ensure equitable access to care for all individuals.
Topics Covered in Male Breast Cancer
BRCA Mutations
Hormonal Risk Factors
Gynecomastia vs Cancer
Delayed Presentation
Mastectomy
Endocrine Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Male Breast Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Male Breast Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Male Breast Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Male Breast Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Male Breast Cancer Conference 2027 — FAQs
What is the Male Breast Cancer track at CIOC 2027?
The Male Breast Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Male Breast Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Male Breast Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Male Breast Cancer are all welcome — whether presenting or attending.
Can I present my research in the Male Breast Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Male Breast Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Male Breast Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.